Ikaria, Inc. Stock

Stocks

IKAR

US45173V1070

Pharmaceuticals

End-of-day quote Nasdaq 5-day change 1st Jan Change
- USD -.--% Intraday chart for Ikaria, Inc. -.--% -
Director TitleAgeSince
Director/Board Member 61 -
Director/Board Member 76 2010-05-18
Director/Board Member 71 -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 0
+0.53%-0.19%+14.72%+72.05% 48.36B
+0.85%+1.53%+60.49%+110.24% 35.8B
+0.04%-1.98%-10.11%+20.62% 11.83B
+1.05%-2.30%+14.54%+72.84% 11.48B
-0.37%-0.37%+37.53%+142.08% 9.01B
+0.12%+1.71%+47.31%-8.48% 6.99B
-0.17%-2.92%+11.72%+31.34% 6.7B
+0.89%-1.23%+3.15%+168.99% 6.42B
-7.92%-13.61%-33.87%-3.30% 5.3B
Average -0.46%-1.90%+16.16%+67.37% 14.19B
Weighted average by Cap. +0.25%-0.45%+24.75%+77.59%
Logo Ikaria, Inc.
Ikaria, Inc. is a United States-based company. The Company operates as a biotherapeutics company focused on developing and commercializing therapeutics for critical care. Its INOtherapy is an offering of drug product, services and technologies. Its product INOtherapy includes INOMAX, which is an treatment for hypoxic respiratory failure in term and near-term infants.
Employees
-
  1. Stock Market
  2. Stocks
  3. IKAR Stock